DeCristo, Molly J.
Brigham and Women's Hospital · Harvard University
2 papers on CoChat
Most cited papers
- Verified
CDK4/6 inhibition triggers anti-tumour immunity
Goel, S., DeCristo, M. J., Watt, A. C., BrinJones, H., Sceneay, J., Li, B. B., Khan, N., Ubellacker, J. M., Xie, S., Metzger-Filho, O., et al. (2017) · Nature
Cancer Immunotherapy and BiomarkersAdvanced Breast Cancer Therapies
Cited by 1,513
- Verified
Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in triple-negative breast cancer
Sceneay, J., Goreczny, G. J., Wilson, K., Morrow, S., DeCristo, M. J., Ubellacker, J. M., Qin, Y., Laszewski, T., Stover, D. G., Barrera, V., et al. (2019) · Cancer Discovery
Cancer Immunotherapy and Biomarkersinterferon and immune responses
Cited by 156
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free